EDGAR Filing Documents for 0001396814-15-000017

Form 8-K - Current report:

SEC Accession No. 0001396814-15-000017

Filing Date

2015-12-18

Accepted

2015-12-17 19:54:35

Documents

Period of Report

2015-12-14

Items

Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	pcrx8-kdec2015.htm	8-K	29189
2	EXHIBIT 16.1	exhibit161.htm	EX-16.1	3766
3		cohnreznicka02.jpg	GRAPHIC	35564
4		crsiga02.jpg	GRAPHIC	10849
	Complete submission text file	0001396814-15-000017.txt		98402

Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054

Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560

Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 151295013
SIC: 2834 Pharmaceutical Preparations